&

Actelion board nominates two

Wednesday, April 6, 2011 12:40 PM

Actelion has nominated two pharmaceutical executives, including ex-GlaxoSmithKline boss Jean-Pierre Garnier, to join the board after shareholder Elliott Advisors repeated calls for changes in management and strategy, according to Pharma Times.

More... »

Eli Lilly CEO says company won’t merge

Tuesday, March 22, 2011 11:25 AM

Eli Lilly, which faces plunging sales due to competition and lapsing patents, will not merge with another company, CEO John Lechleiter said, according to Reuters.

More... »

Report: Big Pharmas embracing technology as they transform to ‘holistic healthcare entities’

Monday, March 14, 2011 07:00 AM

Pharmaceutical companies—having outsourced R&D functions to CROs and collaborated with biotechs, drug companies and academic groups for innovative products and platforms—are now embracing a different type of innovation: technology.

More... »

Kendle names Dr. Martha Feller vice president

Wednesday, March 9, 2011 11:00 AM

CRO Kendle has named Martha R. Feller, Ph.D., vice president and global head of study start-up. Dr. Feller brings to Kendle more than 30 years of senior operations leadership in the clinical development industry, including therapeutic expertise and experience in managing global development programs. She will provide leadership for Kendle's global study start-up function, including management, site identification, regulatory, investigator contracts and essential document collection. 

More... »

Johnson & Johnson recalls Simponi devices

Tuesday, March 1, 2011 08:00 AM

Johnson & Johnson has recalled Simponi injection devices because of their potential to deliver a substandard dose of the arthritis treatment, according to a report in Fierce Pharma.

More... »

ERT names Eric Schwartz chief legal officer

Tuesday, March 1, 2011 08:00 AM

eResearchTechnology, a provider of clinical services and medical devices to biopharmaceutical and healthcare organizations, has named Eric Ian Schwartz executive vice president and chief legal officer.

More... »

Competition aims to recognize, reward skilled U.S. clinical researchers and raise industry profile

Monday, January 24, 2011 12:06 PM

Clinical research associates, study nurses, trial managers and clinical research teams have a chance to win $1,000 prizes in a competition designed to measure their technical and interpersonal skills in a changing global industry and raise the profile of clinical research in the United States.

More... »

Report: Drug discovery industry must embrace open source innovation to speed process, boost bottom lines

Monday, January 3, 2011 07:30 AM

To meet the challenges of research and development, the pharmaceutical industry must adopt more open source innovation—a concept that has been used for nearly three decades by the information technology sector—to promote innovation in the drug discovery process and boost bottom lines, according to a new report by Frost & Sullivan.

More... »

ProPublica report: big pharma paid hundreds of physicians over $100,000 in speaking fees

Monday, November 8, 2010 11:12 AM

Several doctors paid to speak on behalf of big pharmaceutical companies aren’t, in fact, the thought leaders consumers often consider them to be, but instead have been sanctioned for various forms of misconduct. And psychiatrists collect more in speaking and consulting fees from pharma companies than doctors in any other specialty.

More... »

New York Hospital Uses Prepaid Cards to Pay Study Participants

Tuesday, March 23, 2010 06:54 AM

The Theresa & Eugene M. Lang Center for Research & Education—the clinical trial and research arm of New York Hospital Queens (NYHQ)—has replaced its paper-check payment system for clinical trial participants. Instead, patients who earn a stipend for participating in a clinical trial receive a Mastercard card preloaded with their allotted funds.

More... »